Solid forms comprising (5r,6s)-10,11-difluoro-12-((2-fluoro-4-iodophenyl)amino)-5,6-dihydroxy-4,5,6,7-tetrahydro-1h-spiro[benzo[b][1,5,4]oxathiazecine-3,1'-cyclopropane] 2,2-dioxide, and compositions comprising and methods of using the same

MX2026008215APending Publication Date: 2026-10-02PASITHEA THERAPEUTICS CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MX2026008215
Authority / Receiving Office
MX · MX
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-01-02
Filing Date
2026-06-29
Publication Date
2026-10-02
Patent Text Reader

Abstract

Described herein are solid forms of (5R,6S)-10,11-difluoro-12-((2-fluoro-4- iodophenyl)amino)-5,6-dihydroxy -4,5,6, 7 -tetrahydro- 1H-spiro[benzo[b] [1,5, 4]oxathiazecine- 3,1'-cyclopropane] 2,2-dioxide in amorphous and crystalline forms, and processes of preparation, and pharmaceutical compositions thereof. Also provided are methods of their use for treating, preventing, or ameliorating a disease or disorder in which the RAS pathway is upregulated such as cancer, RASopathies and laminopathies. Formula (I).
Need to check novelty before this filing date? Find Prior Art